New Zealand markets closed

PROCEPT BioRobotics Corporation (PRCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
52.09-0.19 (-0.36%)
As of 09:35AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.69B
Enterprise value 2.51B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)18.14
Price/book (mrq)9.57
Enterprise value/revenue 18.42
Enterprise value/EBITDA -25.58

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 372.03%
S&P500 52-week change 321.08%
52-week high 354.79
52-week low 324.83
50-day moving average 349.30
200-day moving average 339.66

Share statistics

Avg vol (3-month) 3488.12k
Avg vol (10-day) 3563.24k
Shares outstanding 551.4M
Implied shares outstanding 651.4M
Float 843.93M
% held by insiders 13.57%
% held by institutions 190.87%
Shares short (15 Apr 2024) 45.36M
Short ratio (15 Apr 2024) 411.94
Short % of float (15 Apr 2024) 414.36%
Short % of shares outstanding (15 Apr 2024) 410.42%
Shares short (prior month 15 Mar 2024) 44.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -77.76%
Operating margin (ttm)-67.82%

Management effectiveness

Return on assets (ttm)-19.11%
Return on equity (ttm)-44.33%

Income statement

Revenue (ttm)136.19M
Revenue per share (ttm)2.88
Quarterly revenue growth (yoy)83.30%
Gross profit (ttm)N/A
EBITDA -105.36M
Net income avi to common (ttm)-105.9M
Diluted EPS (ttm)-2.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)257.22M
Total cash per share (mrq)5.05
Total debt (mrq)81.09M
Total debt/equity (mrq)28.88%
Current ratio (mrq)7.63
Book value per share (mrq)5.53

Cash flow statement

Operating cash flow (ttm)-108M
Levered free cash flow (ttm)-106.37M